8:31 AM ET
8-K
Other 8-K Filing
Ensysce Biosciences Other 8-K Filing
Ensysce Biosciences filed an amendment to its Series C Non-Voting Convertible Preferred Stock certificate of designation to remove a cash redemption option. Previously, Section 6.5.3 allowed holders to redeem shares for cash if the company failed to deliver common stock upon conversion; this provision has now been eliminated.